Brooks Rehabilitation Center
Jacksonville, Florida, 32216, United States
Location status: Recruiting
NCT Number: NCT07554443
The goal of this clinical trial is to investigate whether sensory stimulations from a neuroprosthesis device (Walkasins®) can increase physical activity and improve gait quality in persons with peripheral neuropathy (PN). The main question it aims to answer is whether Walkasins enhances habitual activity patterns in adults with peripheral neuropathy.
Participants will do the following as part of the study:
* Complete a sensation and balance assessment to determine eligibility for the study. * Answer questions about their medical history, physical function, balance confidence, and sleep. * Perform various balance and walking tasks on three separate occasions. One of the tests involves walking for six minutes without a cane or walker. * Wear an activPAL activity monitor for ten days on three separate occasions and return it to the researcher as directed. * Wear Walkasins for ten weeks as part of their daily routine. Walkasins consists of two parts: 1) an insole that fits inside the shoe and 2) a strap that secures around the ankle.
Interested in participating?
Request Info60 year and older
All sexes
Interventional
Not applicable
Jacksonville, Florida, 32216, United States
Location status: Recruiting
This will be a prospective within-participant study design conducted over a period of one year. After providing informed consent, all participants will undergo a battery of instrumented mobility assessments (e.g., 6-minute walk test [6MWT], Functional Gait Assessment [FGA], etc.), questionnaires, and a 10-day habitual physical activity observation period, wearing an electronic event logger to derive the primary outcomes. This initial (baseline) assessment, without the sensory assistance of the Walkasins, will allow participants to serve as their own control. Assessment and observation periods will be repeated at the dispensing of the Walkasins device and after participants have acclimated to daily use, 10 weeks after participants have begun wearing the device.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Walkasins is an external, lower limb sensory prosthesis intended to replace part of the nerve function used for detection and signaling of foot pressure sensation during standing and walking activities. Walkasins consist of two parts for each leg: the Haptic Module and the Receptor Sole. The Haptic Module wraps around the lower leg of the user and contains electronics for reading Receptor Sole pressure signals, a microprocessor, and four vibrating motors that provide gentle tactile sensory cues to the front, back, medial, and lateral surfaces of the user's leg. These cues reflect real-time foot pressure information at a location above the ankle where skin sensation is still present.
Time frame: Over a period of ~12 weeks
The Activity Score, expressed in metabolic equivalents (METs), reflects the overall intensity of physical activity performed. (One MET is defined as the energy a person uses when resting or sitting still.) Higher MET values indicate greater energy expenditure and higher levels of physical activity, while lower values suggest reduced activity intensity and increased sedentary behavior.
Time frame: Over a period of ~12 weeks
Step count reflects the total number of steps accumulated over a given period and serves as an indicator of overall daily ambulatory activity. Lower step counts are associated with reduced physical activity levels and decreased functional mobility.
Time frame: Over a period of ~12 weeks
Total sedentary time reflects the individual's overall inactivity during the day. Prolonged sedentary behavior may contribute to deconditioning, decreased functional capacity, and increased risk for chronic disease.
Time frame: Baseline, Walkasins Initiation, Follow-up (Week 10)
The 6 Minute Walk Test is an exercise test used to evaluate aerobic capacity and endurance. The distance a subject walks in six minutes is the outcome by which to compare changes in performance capacity. Participants will wear sensors during the test that will allow for calculation of Phase Coordination Index (PCI) scores. A PCI score closer to zero indicates better bilateral coordination or better phase generation accuracy and/or consistency within the gait cycle.
Time frame: Baseline, Walkasins Initiation, Follow-up (Week 10)
The ABC Scale is a 16-item self-report measure of an individual's confidence in their ability to maintain balance while performing various daily activities. Scores range from 0% to 100% to reflect perceived balance confidence, with lower scores indicating greater fear of falling and increased risk of mobility limitations.
Time frame: Baseline, Walkasins Initiation, Follow-up (Week 10)
The International Physical Activity Questionnaire (IPAQ short form) can be used to obtain comparable estimates of physical activity between populations and countries. It consists of four questions that ask participants to state how much time they have spent engaged in various activities over the past 7 days. A higher score on the International Physical Activity Questionnaire (IPAQ) is better. The IPAQ measures physical activity in MET-minutes/week, where higher scores indicate greater physical activity, categorizing individuals as low, moderate, or high (3000+ MET-min/week) in terms of activity levels. (A MET [Metabolic Equivalent of Task] is a unit used to measure the energy expenditure and intensity of physical activities relative to resting, defined as the oxygen consumption of 3.5 mL/kg/min.)
Time frame: Baseline, Walkasins Initiation, Follow-up (Week 10)
The PROMIS® Pain Intensity assessment was developed to capture the overall level of pain experienced by the individual, independent of its cause or location, allowing comparisons across patient groups and over time. It consists of three questions, rated on a scale from "No pain" to "Very severe" with higher scores indicative of greater pain intensity.
Time frame: Baseline, Walkasins Initiation, Follow-up (Week 10)
PROMIS® PROWalk is a patient-reported outcome measure assessing perceived walking-related functional limitations. It captures individuals' subjective experiences of mobility challenges with lower scores indicating greater physical function impairment. Participants rate their physical function on nine tasks, using a scale of 1 (Unable to do) to 5 (Without any difficulty).
Time frame: Baseline, Walkasins Initiation, Follow-up (Week 10)
PROMIS Sleep-Related Impairment assesses the daytime effects of poor or insufficient sleep, such as sleepiness, fatigue, difficulty concentrating, and reduced ability to perform daily activities, also over the past 7 days.
Together, these complementary measures capture both sleep quality and the functional impact of sleep problems from the patient's perspective.
PROMIS Sleep Disturbance measures perceived problems with sleep itself, including difficulty falling or staying asleep, restlessness, and overall sleep quality over the past 7 days. It reflects the individual's experience during the sleep period. Both are 8-item assessments with higher scores indicating more sleep dysfunction.
Time frame: Baseline, Walkasins Initiation, Follow-up (Week 10)
Gait speed will be measured through the 10-Meter Walk Test, timing the middle 10 meters with two meters before and after to allow for acceleration and deceleration. Participants will be instructed to walk at normal speed. Higher numbers indicate faster speeds (i.e., more meters per second).
Time frame: Baseline, Walkasins Initiation, Follow-up (Week 10)
The 2-Minute Dual-Task Walk is a measurement of endurance that assesses walking distance over two minutes while also performing a cognitive task (e.g., counting down by 7s from a given number). Greater distances indicate better physical functioning and mobility.
Time frame: Baseline, Walkasins Initiation,
The Timed Up and Go Test is part of the Centers for Disease Control (CDC)-recommended STEADI test protocol for balance function. From a seated position in a standard armchair, the participant is asked to stand up from the chair, walk to a line on the floor 10 feet away at normal pace, turn, walk back to the chair at normal pace, and sit down again. The tester records the time taken from the command "Go" until the subject sits down again. Lower times indicate better/faster performance.
Time frame: Baseline, Walkasins Initiation, Follow-up (Week 10)
The Modified Clinical Test of Sensory Interaction in Balance assesses a participant's capacity to sustain balance across four conditions to measure their postural control ability: 1) firm surface eyes open, 2) firm surface eyes closed, 3) foam surface eyes open, and 4) foam surface eyes closed. Participants will stand in each condition for 30 seconds or until they open their eyes in the eyes closed conditions or drop their hands from their hips in the eyes open conditions. Less sway, as measured by sensors, indicates better postural control.
Time frame: Baseline, Walkasins Initiation, Follow-up (Week 10)
The Single Leg Stance Test (also called the unipedal stance test) "is a simple test for measuring static aspects of balance." It "is related to conditions such as peripheral neuropathy and intermittent claudication" and "is also associated with an increased risk for falls" (Springer BA, Marin R, Cyhan T, Roberts H, Gill NW. Normative values for the unipedal stance test with eyes open and closed. Journal of geriatric physical therapy. 2007 Apr 1;30(1):8-15). Participants stand unassisted on one leg with their hands on their hips. Timing begins when they lift one leg off the floor and ends when it touches the ground or the standing leg or an arm leaves the hips
Time frame: Baseline, Walkasins Initiation, Follow-up (Week 10)
The Functional Gait Assessment (FGA) is a 10-item scale that measures postural stability while individuals perform walking tasks that are scored from 0 to 3 (3 = normal, 2 = mild impairment, 1 = moderate impairment, 0 = severe impairment). Scores range from a minimum of 0 to a maximum of 30. Higher scores indicate better postural stability.
Time frame: Baseline
The Centers for Medicare & Medicaid Services (CMS) identifies the monofilament test as the means of diagnosing loss of protective sensation (https://www.cms.gov/medicare-coverage-database/view/ncd.aspx?NCDId=171). To conduct the test, a clinician applies pressure with various sizes of monofilament to selected parts of the foot and asks the participant to indicate when he/she feels the filament. Per CMS, inability to feel a 10-gram monofilament on at least two of five test sites on either foot indicates loss of protective sensation (LOPS). For this study participants will undergo testing on at four sites on the dominant foot with a 2g and/or 10g monofilament.
Contact information is provided by the study sponsor or research team.
Dorian Rose, PT, MS, PhD, FAPTA
CONTACT
Hannah Grimes
CONTACT
RxFunction Inc.
Industry
Wearable Sensory Prostheses to Improve Neuromuscular Coordination, Walking Function, and Real-World Physical Activity
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06959277
Balance Control in Elderly, Gait Disorders
Mesa, Arizona, United States
View Trial DetailsNCT07509671
Diabetes Complications, Diabetes Mellitus
Hendersonville, North Carolina, United States
View Trial DetailsNCT05577390
Diabetes Mellitus, Diabetes Mellitus, Type 2
Loma Linda, California, United States
View Trial DetailsNCT07645482
Peripheral Neuropathy With Type 2 Diabetes
Giza, Egypt
View Trial Details